138 related articles for article (PubMed ID: 28848701)
1. Trans-arterial chemoperfusion for the treatment of liver metastases of breast cancer and colorectal cancer: Clinical results in palliative care patients.
Gruber-Rouh T; Langenbach M; Naguib NNN; Nour-Eldin NM; Vogl TJ; Zangos S; Beeres M
World J Clin Oncol; 2017 Aug; 8(4):343-350. PubMed ID: 28848701
[TBL] [Abstract][Full Text] [Related]
2. [Transarterial chemoperfusion of the pelvis--results in symptomatic locally recurrent tumors and lymph node metastases].
Vogl TJ; Zangos S; Eichler K; Balzer JO; Jacob U; Keilhauer R; Bauer RW
Rofo; 2007 Nov; 179(11):1174-80. PubMed ID: 17805998
[TBL] [Abstract][Full Text] [Related]
3. Breast adenocarcinoma liver metastases, in contrast to colorectal cancer liver metastases, display a non-angiogenic growth pattern that preserves the stroma and lacks hypoxia.
Stessels F; Van den Eynden G; Van der Auwera I; Salgado R; Van den Heuvel E; Harris AL; Jackson DG; Colpaert CG; van Marck EA; Dirix LY; Vermeulen PB
Br J Cancer; 2004 Apr; 90(7):1429-36. PubMed ID: 15054467
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant TACE before laser induced thermotherapy (LITT) in the treatment of non-colorectal non-breast cancer liver metastases: feasibility and survival rates.
Vogl TJ; Kreutzträger M; Gruber-Rouh T; Eichler K; Nour-Eldin NE; Zangos S; Naguib NN
Eur J Radiol; 2014 Oct; 83(10):1804-10. PubMed ID: 25082479
[TBL] [Abstract][Full Text] [Related]
5. Transarterial chemoembolization of unresectable systemic chemotherapy-refractory liver metastases from colorectal cancer: long-term results over a 10-year period.
Gruber-Rouh T; Naguib NN; Eichler K; Ackermann H; Zangos S; Trojan J; Beeres M; Harth M; Schulz B; Nour-Eldin A NE; Vogl TJ
Int J Cancer; 2014 Mar; 134(5):1225-31. PubMed ID: 23960002
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
[TBL] [Abstract][Full Text] [Related]
7. Seeding after ultrasound-guided percutaneous biopsy of liver metastases in patients with colorectal or breast cancer.
Chen I; Lorentzen T; Linnemann D; Nolsøe CP; Skjoldbye B; Jensen BV; Nielsen D
Acta Oncol; 2016 May; 55(5):638-43. PubMed ID: 26457338
[TBL] [Abstract][Full Text] [Related]
8. 5-FU or mitomycin C hepatic arterial infusion after failure of arterial oxaliplatin in patients with colorectal cancer unresectable liver metastases.
Pernot S; Velut G; Kourie RH; Amouyal G; Sapoval M; Pointet AL; Landi B; Zaimi Y; Lepère C; Pellerin O; Taieb J
Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):255-260. PubMed ID: 29233520
[TBL] [Abstract][Full Text] [Related]
9. Arterial chemotherapy of 5-fluorouracil and mitomycin C in the treatment of liver metastases of colorectal cancer.
Liu LX; Zhang WH; Jiang HC; Zhu AL; Wu LF; Qi SY; Piao DX
World J Gastroenterol; 2002 Aug; 8(4):663-7. PubMed ID: 12174375
[TBL] [Abstract][Full Text] [Related]
10. Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer.
Narayanan G; Barbery K; Suthar R; Guerrero G; Arora G
Anticancer Res; 2013 May; 33(5):2077-83. PubMed ID: 23645758
[TBL] [Abstract][Full Text] [Related]
11. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM
Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-Weighted MR Imaging of Primary and Secondary Lung Cancer: Predictive Value for Response to Transpulmonary Chemoembolization and Transarterial Chemoperfusion.
Vogl TJ; Hoppe AT; Gruber-Rouh T; Basten L; Dewes P; Hammerstingl RM; Balaban Ü; Mastrodicasa D; Thompson ZM; Albrecht MH
J Vasc Interv Radiol; 2020 Feb; 31(2):301-310. PubMed ID: 31899107
[TBL] [Abstract][Full Text] [Related]
13. Impact of primary tumour location on colorectal liver metastases: A systematic review.
Bingham G; Shetye A; Suresh R; Mirnezami R
World J Clin Oncol; 2020 May; 11(5):294-307. PubMed ID: 32728532
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival of patients with unresectable colorectal liver metastases treated by percutaneous interstitial laser thermotherapy.
Christophi C; Nikfarjam M; Malcontenti-Wilson C; Muralidharan V
World J Surg; 2004 Oct; 28(10):987-94. PubMed ID: 15573253
[TBL] [Abstract][Full Text] [Related]
15. A phase I/II study of hepatic artery infusion with wtp53-CMV-Ad in metastatic malignant liver tumours.
Habib NA; Hodgson HJ; Lemoine N; Pignatelli M
Hum Gene Ther; 1999 Aug; 10(12):2019-34. PubMed ID: 10466636
[TBL] [Abstract][Full Text] [Related]
16. The potential of recombinant vesicular stomatitis virus-mediated virotherapy against metastatic colon cancer.
Yamaki M; Shinozaki K; Sakaguchi T; Meseck M; Ebert O; Ohdan H; Woo SL
Int J Mol Med; 2013 Feb; 31(2):299-306. PubMed ID: 23232984
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer liver metastases - a population-based study on incidence, management and survival.
Engstrand J; Nilsson H; Strömberg C; Jonas E; Freedman J
BMC Cancer; 2018 Jan; 18(1):78. PubMed ID: 29334918
[TBL] [Abstract][Full Text] [Related]
18. Hepatic intra-arterial chemotherapy using a percutaneous catheter in pretreated patients with metastatic colorectal carcinoma.
Fazio N; Orsi F; Grasso RF; Ferretti G; Medici M; Rocca A; Zampino G; Curigliano G; De Pas T; Colleoni M; Bonomo G; Marrocco E; Lunghi L; De Braud F
Anticancer Res; 2003; 23(6D):5023-30. PubMed ID: 14981962
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.
Schmeel FC; Simon B; Sabet A; Luetkens JA; Träber F; Schmeel LC; Ezziddin S; Schild HH; Hadizadeh DR
Eur Radiol; 2017 Mar; 27(3):966-975. PubMed ID: 27271923
[TBL] [Abstract][Full Text] [Related]
20. Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer.
Bouchahda M; Boige V; Smith D; Karaboué A; Ducreux M; Hebbar M; Lepère C; Focan C; Guimbaud R; Innominato P; Awad S; Carvalho C; Tumolo S; Truant S; De Baere T; Castaing D; Rougier P; Morère JF; Taieb J; Adam R; Lévi F;
Eur J Cancer; 2016 Nov; 68():163-172. PubMed ID: 27768923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
